Research Paper Volume 15, Issue 21 pp 11891—11917
Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker
Figure 3. The gene mutation character of XCL2 in pan-cancer. (A) The mutation sites, types of mutation, and alteration frequency of XCL2 somatic mutation; (B, C) The mutation frequency of XCL2 in various cancer using the cBioPortal database; (D, E) The correlation of CNV with XCL2 mRNA expression and 5 XCL-related genes in 33 cancers; (F) The co-expression between MMR-related genes and XCL2; (G, H) The correlation of methylation with mRNA expression of XCL2 and 5 XCL-related genes in 33 cancers; (I) The co-expression between methylation-related genes and XCL2 (*P < 0.05, **P < 0.01, ***P < 0.001).